Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2016-06-30
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mind Programme for Women With Breast Cancer (Nationwide Coverage)
NCT06212414
Mind Programme for Women With Breast Cancer
NCT05642897
Effectiveness of an Individual Mindfulness-based Intervention for Cancer Patients in a Advanced Stage of the Disease and Their Relatives
NCT03492073
Effectiveness of Blended and Unguided Delivery of Mindfulness-based Cognitive Therapy for Cancer Patients
NCT05336916
One-day Mind Programme for Women With Breast Cancer
NCT06852833
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Afterwards, participants will be allocated in two groups (experimental and control group). Both groups will maintain the medical treatment as usual (TAU). Additionally, the experimental group will enroll in the MIND programme for cancer patients, also provided by a licensed psychologist.
Both groups will concurrently complete a protocol of self-report measures and their medical data will be collected by the medical staff of the Hospital.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MIND Programme for cancer
MIND programme for cancer is a manualized acceptance, mindfulness and compassionate-based group intervention for cancer patients. It included 8 weekly group sessions, 2h hours each, run in small groups (ranging from 6 to 12 participants).
Participants in this group also receive cancer treatment as usually performed at the Coimbra University Hospital.
MIND programme for cancer patients
Psychotherapeutic programme based on Acceptance, Mindfulness and Compassion for cancer patients Other: Cancer Treatment as Usual
Treatment as Usual (TAU)
Standard personalized treatment of cancer
Treatment as Usual (TAU)
Cancer treatment as usually performed at the Coimbra University Hospital.
Treatment as Usual (TAU)
Standard personalized treatment of cancer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MIND programme for cancer patients
Psychotherapeutic programme based on Acceptance, Mindfulness and Compassion for cancer patients Other: Cancer Treatment as Usual
Treatment as Usual (TAU)
Standard personalized treatment of cancer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* difficulty in completing self-report measures
18 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Coimbra
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
InĂªs A Trindade
PhD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SFRH/BD/101906/2014
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
CINEICC-1-IAT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.